Pfizer is fined $430 million for illegal marketing practices surrounding the drug Neurontin. The unprecedented fine comes after the company admitted that the epilepsy drug was promoted for several unapproved uses, including migraines, chronic pain and bipolar disease.
States had complained that the company's marketing practices inflated the costs of the Medicaid program for the poor. NPR's Snigdha Prakash reports.
Copyright 2022 NPR. To see more, visit https://www.npr.org.
